Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.
Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Munson ML, Chen YC, Najera I, Thommes J; PROPEL Investigators. Wedemeyer H, et al. Among authors: munson ml. Hepatology. 2013 Aug;58(2):524-37. doi: 10.1002/hep.26274. Epub 2013 Jun 26. Hepatology. 2013. PMID: 23348636 Clinical Trial.
The effect of mild to moderate renal impairment on the pharmacokinetics of the nucleoside analog hepatitis C virus polymerase inhibitor mericitabine.
Haznedar J, Moreira S, Marbury T, Robson R, Smith W, Kulkarni R, Munson ML, Thommes JA, Lemenuel-Diot A, Washington C, Smith P, Chen YC. Haznedar J, et al. Among authors: munson ml. Drug Dev Res. 2014 Mar;75(2):107-13. doi: 10.1002/ddr.21166. Epub 2013 Dec 26. Drug Dev Res. 2014. PMID: 24648253 Clinical Trial.
A prospective observational safety study of patients with BRAFV 600 -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study).
Corrie PG, Terheyden P, Ten Tije AJ, Herbst R, Jansen R, Marples M, Debus D, Marconcini R, Blasinska-Morawiec M, Freivogel K, Munson MLG, Goodman GR, Hsu JJ, Sadetsky N, Colburn D, Rutkowski P. Corrie PG, et al. Among authors: munson mlg. Br J Dermatol. 2019 May;180(5):1254-1255. doi: 10.1111/bjd.17465. Epub 2019 Feb 10. Br J Dermatol. 2019. PMID: 30488430 No abstract available.
Births: final data for 2005.
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, Munson ML; Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Martin JA, et al. Among authors: munson ml. Natl Vital Stat Rep. 2007 Dec 5;56(6):1-103. Natl Vital Stat Rep. 2007. PMID: 18277471 Free article.
Fetal and perinatal mortality, United States, 2004.
MacDorman MF, Munson ML, Kirmeyer S. MacDorman MF, et al. Among authors: munson ml. Natl Vital Stat Rep. 2007 Oct 11;56(3):1-19. Natl Vital Stat Rep. 2007. PMID: 17983023 Free article.
Fetal and perinatal mortality, United States, 2003.
MacDorman MF, Hoyert DL, Martin JA, Munson ML, Hamilton BE. MacDorman MF, et al. Among authors: munson ml. Natl Vital Stat Rep. 2007 Feb 21;55(6):1-17. Natl Vital Stat Rep. 2007. PMID: 17354646 Free article.
Births: final data for 2003.
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Martin JA, et al. Among authors: munson ml. Natl Vital Stat Rep. 2005 Sep 8;54(2):1-116. Natl Vital Stat Rep. 2005. PMID: 16176060 Free article.
Births: final data for 2002.
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Martin JA, et al. Among authors: munson ml. Natl Vital Stat Rep. 2003 Dec 17;52(10):1-113. Natl Vital Stat Rep. 2003. PMID: 14717305 Free article.